Stay updated on Upadacitinib in Giant Cell Arteritis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.

Latest updates to the Upadacitinib in Giant Cell Arteritis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedUpdated the revision label from v3.0.2 to v3.2.0, indicating a newer version has been released. No other content changes observed.SummaryDifference0.0%
- Check21 days agoChange DetectedUpdate: version label changed from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.0%
- Check28 days agoChange DetectedRemoved explicit sections or terms related to drug safety and quality (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs).SummaryDifference0.1%
- Check35 days agoChange DetectedUpdated to Revision v3.0.2 from v3.0.1; removed the 'Back to Top' element.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.1%
- Check50 days agoChange DetectedThe webpage has been updated to include new facility names and locations across various countries, while also removing outdated location references. Additionally, new publications related to drug safety and treatment for temporal arteritis have been added.SummaryDifference11%
Stay in the know with updates to Upadacitinib in Giant Cell Arteritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Giant Cell Arteritis Clinical Trial page.